AAAAAA

   
Results: 1-15 |
Results: 15

Authors: van Tilburg, EW van der Klein, PAM de Groote, M Beukers, MW Ijzerman, AP
Citation: Ew. Van Tilburg et al., Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor, BIOORG MED, 11(15), 2001, pp. 2017-2019

Authors: van Muijlwijk-Koezen, JE Timmerman, H Vollinga, RC Kunzel, JFV de Groote, M Visser, S Ijzerman, AP
Citation: Je. Van Muijlwijk-koezen et al., Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists, J MED CHEM, 44(5), 2001, pp. 749-762

Authors: Schrier, SM van Tilburg, EW van der Meulen, H Ijzerman, AP Mulder, GJ Nagelkerke, JF
Citation: Sm. Schrier et al., Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells - Studies on involvement of adenosine receptors and adenosine uptake, BIOCH PHARM, 61(4), 2001, pp. 417-425

Authors: Kourounakis, AP Van der Klein, PAM Ijzerman, AP
Citation: Ap. Kourounakis et al., Elucidation of structure-activity relationships of 2-amino-3-benzoylthiophenes: Study of their allosteric enhancing vs. antagonistic activity on adenosine A(1) receptors, DRUG DEV R, 49(4), 2000, pp. 227-237

Authors: de Zwart, M de Groote, M van der Klein, PAM van Dun, S Bronsing, R Kunzel, JKVD Ijzerman, AP
Citation: M. De Zwart et al., Phenyl-substituted N-6-phenyladenosines and N-6-phenyl-5 '-N-ethylcarboxamidoadenosines with high activity at human adenosine A(2B) receptors, DRUG DEV R, 49(2), 2000, pp. 85-93

Authors: Beukers, MW Den Dulk, H Van Tilburg, EW Brouwer, J Ijzerman, AP
Citation: Mw. Beukers et al., Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A2B receptor for 2-(1-hexynyl) adenosine, MOLEC PHARM, 58(6), 2000, pp. 1349-1356

Authors: Vittori, S Lorenzen, A Stannek, C Costanzi, S Volpini, R Ijzerman, AP Kunzel, JKVD Cristalli, G
Citation: S. Vittori et al., N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists andpartial agonists of the A(1) adenosine receptor, J MED CHEM, 43(2), 2000, pp. 250-260

Authors: deLigt, RAF Kourounakis, AP Ijzerman, AP
Citation: Raf. Deligt et al., Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery (vol 130, pg 1, 2000), BR J PHARM, 131(1), 2000, pp. 160-160

Authors: de Ligt, RAF Kourounakis, AP Ijzerman, AP
Citation: Raf. De Ligt et al., Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery, BR J PHARM, 130(1), 2000, pp. 1-12

Authors: Beukers, MW Kristiansen, K Ijzerman, AP Edvardsen, O
Citation: Mw. Beukers et al., TinyGRAP database: a bioinformatics tool to mine G-protein-coupled receptor mutant data, TRENDS PHAR, 20(12), 1999, pp. 475-477

Authors: de Zwart, M Vollinga, RC Beukers, MW Sleegers, DF Kunzel, JKVD de Groote, M Ijzerman, AP
Citation: M. De Zwart et al., Potent antagonists for the human adenosine A(2B) receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity, DRUG DEV R, 48(3), 1999, pp. 95-103

Authors: Jacobson, KA Ijzerman, AP Linden, J
Citation: Ka. Jacobson et al., 1,3-dialkylxanthine derivatives having high potency as antagonists at human A(2B) adenosine receptors, DRUG DEV R, 47(1), 1999, pp. 45-53

Authors: Zuurmond, HM Hessling, J Bluml, K Lohse, M Ijzerman, AP
Citation: Hm. Zuurmond et al., Study of interaction between agonists and Asn293 in helix VI of human beta(2)-adrenergic receptor, MOLEC PHARM, 56(5), 1999, pp. 909-916

Authors: Ingkaninan, K Ijzerman, AP Taesotikul, T Verpoorte, R
Citation: K. Ingkaninan et al., Isolation of opioid-active compounds from Tabernaemontana pachysiphon leaves, J PHARM PHA, 51(12), 1999, pp. 1441-1446

Authors: Van der Graaf, PH Van Schaick, EA Visser, SAG De Greef, HJMM Ijzerman, AP Danhof, M
Citation: Ph. Van Der Graaf et al., Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: Prediction of tissue-dependent efficacy in vivo, J PHARM EXP, 290(2), 1999, pp. 702-709
Risultati: 1-15 |